ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

CASI Pharmaceuticals, Inc. clinical trials

Also known as EntreMed.

Its pipeline, or its studies — you choose. Free with an account during the beta.

The registry lists 25 studies whose lead sponsor is CASI Pharmaceuticals, Inc. or the company grouped under it. 3 are recruiting or about to start. Per ClinicalTrials.gov, last updated Nov 18, 2026.

Our grouping of 3 registry names, not the registry’s. See them and correct one ↓

Compare CASI Pharmaceuticals with Novartis and Amgen →

Pipeline: 1 program

Each counted once: 1 with a study CASI Pharmaceuticals, Inc. leads registered in the last two years.

  • Phase 2

The 1 program — sign in to see the list, free: with every program, filter by condition or phase and sort by first study or primary completion.

“Registry” is the highest phase of CASI Pharmaceuticals, Inc.’s own registered studies; CASI Pharmaceuticals, Inc.’s own pipeline document is not read yet. “Primary completion” is the earliest date still ahead among its live studies when the main measure’s data collection ends, as the registry states it (most are estimates); results come later, if they are announced. Programs are read from ClinicalTrials.gov, joined across names by rules and decisions each recorded with its evidence.

What it is testing

The drugs CASI Pharmaceuticals, Inc.’s studies test, most open studies first — 9 drugs with a page of their own. Each count opens the studies in search.

Open now Not open: under way, finished or stopped

What changed recently

From the registry's own updates since Oct 19, 2026.

All 25 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Open now312%Recruiting 2 · Not yet recruiting 1
  • Completed2288%

Phase

  • Phase 218
  • Phase 19
  • Phase 41

Where

  • United States17
  • China5
  • Canada4
  • France1
  • United Kingdom1

Over the years

  1. 07
  2. 408
  3. 09
  4. 10
  5. 11
  6. 12
  7. 13
  8. 14
  9. 15
  10. 16
  11. 17
  12. 18
  13. 19
  14. 20
  15. 21
  16. 22
  17. 23
  18. 24
  19. 25
  20. 226

By the year each study started; 8 started before 2007. 2026 so far in the lighter column.

Registry sponsor names on this page

Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.

Tell us about a missing company
No account needed. Please leave out personal details.

Each name exactly as ClinicalTrials.gov lists it, and how it relates to CASI Pharmaceuticals, Inc.

  • CASI Pharmaceuticals, Inc.
    Same company
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    22 studies
  • CASI pharmaceuticals, Inc.
    Same company
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    2 studies
  • CASI Pharmaceuticals (China) Co., Ltd.
    Regional office
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    1 study →

Studies

Recruiting first, then most recently updated. Showing 25 of 25.